Mutations of the p53 suppressor gene have been shown to be potentially useful as a prognostic indicator of tumor aggressiveness. We will study 85 cases of breast cancer utilizing immunohistochemistry and will correlate the expression of this protein with amplification of c-erbB2 protein.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Intramural Research (Z01)
Project #
1Z01SC009361-06
Application #
2464516
Study Section
Special Emphasis Panel (LP)
Project Start
Project End
Budget Start
Budget End
Support Year
6
Fiscal Year
1996
Total Cost
Indirect Cost
Name
National Cancer Institute Division of Clinical Sciences
Department
Type
DUNS #
City
State
Country
United States
Zip Code